<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>During a 15-year period, 161 adult patients were diagnosed with secondary <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (s-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) in the region of Southern Denmark </plain></SENT>
<SENT sid="1" pm="."><plain>In 73 patients, the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> diagnosis was preceded by <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), in 31 patients by an antecedent <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematologic disease</z:e>, and in 57 patients by treatment with chemotherapy and/or irradiation (t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Cytogenetic analysis was carried out in 93%, of which 61% had clonal chromosome aberrations </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> correlated to a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype (P &lt; 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> correlated to abnormal clones with numerical and structural aberrations (P = 0.03), five or more unrelated aberrations (P = 0.03), marker chromosomes (P = 0.006), abnormal mitoses only (P = 0.01), female sex (P &lt; 0.001), and -7 (P = 0.006) </plain></SENT>
<SENT sid="5" pm="."><plain>Centromeric breakage correlated to a complex karyotype (P = 0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>The frequencies of aberrations in s-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients were compared with an age-matched group of de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients diagnosed in the same area and period </plain></SENT>
<SENT sid="7" pm="."><plain>In this comparison, s-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> only correlated to -7 (P = 0.02) </plain></SENT>
<SENT sid="8" pm="."><plain>In 42 patients, we found that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with an abnormal karyotype were more likely to show cytogenetic evolution during progression to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> than <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype (P = 0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>We conclude that population-based cytogenetic studies of adult s-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and age- and sex-matched de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> show comparable distributions of chromosome abnormalities </plain></SENT>
</text></document>